| Title |
Pharmacokinetic and Immunological Considerations for Expanding the Therapeutic Window of Next-Generation Antibody–Drug Conjugates
|
|---|---|
| Published in |
BioDrugs, August 2018
|
| DOI | 10.1007/s40259-018-0302-5 |
| Pubmed ID | |
| Authors |
Eshita Khera, Greg M. Thurber |
Mendeley readers
The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 66 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 16 | 24% |
| Researcher | 12 | 18% |
| Student > Master | 5 | 8% |
| Student > Bachelor | 4 | 6% |
| Other | 3 | 5% |
| Other | 6 | 9% |
| Unknown | 20 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Chemistry | 10 | 15% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 12% |
| Biochemistry, Genetics and Molecular Biology | 7 | 11% |
| Chemical Engineering | 4 | 6% |
| Agricultural and Biological Sciences | 4 | 6% |
| Other | 8 | 12% |
| Unknown | 25 | 38% |